Obesity, metabolic syndrome, and cardiovascular disease

Research output: Contribution to journalArticle

770 Citations (Scopus)

Abstract

Obesity is a major underlying risk factor for ASCVD. It is associated with multiple ASCVD risk factors, and it also is a risk factor for type 2 diabetes. Diabetes itself is a cardiovascular risk factor. Despite the strong association between obesity and ASCVD, the mechanisms underlying this relationship are not well understood. Our understanding of the connection between obesity and vascular disease is complicated by a plethora of possibilities. Obesity acts on so many metabolic pathways, producing so many potential risk factors, that it is virtually impossible to differentiate between the more important and less important. The possibilities for confounding variables are enormous. This complexity provides a great challenge for basic and clinical research. It also raises the possibility for new targets of therapy for the metabolic syndrome. With this said, the fundamental challenge is how to intervene at the public health level to reduce the high prevalence of obesity in the general population. This approach offers the greatest possibility for reducing the cardiovascular risk that accompanies obesity.

Original languageEnglish (US)
Pages (from-to)2595-2600
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number6
DOIs
StatePublished - Jun 2004

Fingerprint

Metabolic Diseases
Cardiovascular Diseases
Obesity
Medical problems
Confounding Factors (Epidemiology)
Public health
Metabolic Networks and Pathways
Vascular Diseases
Type 2 Diabetes Mellitus
Public Health
Research
Population

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Obesity, metabolic syndrome, and cardiovascular disease. / Grundy, Scott M.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 6, 06.2004, p. 2595-2600.

Research output: Contribution to journalArticle

@article{294e6f15e67c4f84b082d6abc44a1294,
title = "Obesity, metabolic syndrome, and cardiovascular disease",
abstract = "Obesity is a major underlying risk factor for ASCVD. It is associated with multiple ASCVD risk factors, and it also is a risk factor for type 2 diabetes. Diabetes itself is a cardiovascular risk factor. Despite the strong association between obesity and ASCVD, the mechanisms underlying this relationship are not well understood. Our understanding of the connection between obesity and vascular disease is complicated by a plethora of possibilities. Obesity acts on so many metabolic pathways, producing so many potential risk factors, that it is virtually impossible to differentiate between the more important and less important. The possibilities for confounding variables are enormous. This complexity provides a great challenge for basic and clinical research. It also raises the possibility for new targets of therapy for the metabolic syndrome. With this said, the fundamental challenge is how to intervene at the public health level to reduce the high prevalence of obesity in the general population. This approach offers the greatest possibility for reducing the cardiovascular risk that accompanies obesity.",
author = "Grundy, {Scott M}",
year = "2004",
month = "6",
doi = "10.1210/jc.2004-0372",
language = "English (US)",
volume = "89",
pages = "2595--2600",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Obesity, metabolic syndrome, and cardiovascular disease

AU - Grundy, Scott M

PY - 2004/6

Y1 - 2004/6

N2 - Obesity is a major underlying risk factor for ASCVD. It is associated with multiple ASCVD risk factors, and it also is a risk factor for type 2 diabetes. Diabetes itself is a cardiovascular risk factor. Despite the strong association between obesity and ASCVD, the mechanisms underlying this relationship are not well understood. Our understanding of the connection between obesity and vascular disease is complicated by a plethora of possibilities. Obesity acts on so many metabolic pathways, producing so many potential risk factors, that it is virtually impossible to differentiate between the more important and less important. The possibilities for confounding variables are enormous. This complexity provides a great challenge for basic and clinical research. It also raises the possibility for new targets of therapy for the metabolic syndrome. With this said, the fundamental challenge is how to intervene at the public health level to reduce the high prevalence of obesity in the general population. This approach offers the greatest possibility for reducing the cardiovascular risk that accompanies obesity.

AB - Obesity is a major underlying risk factor for ASCVD. It is associated with multiple ASCVD risk factors, and it also is a risk factor for type 2 diabetes. Diabetes itself is a cardiovascular risk factor. Despite the strong association between obesity and ASCVD, the mechanisms underlying this relationship are not well understood. Our understanding of the connection between obesity and vascular disease is complicated by a plethora of possibilities. Obesity acts on so many metabolic pathways, producing so many potential risk factors, that it is virtually impossible to differentiate between the more important and less important. The possibilities for confounding variables are enormous. This complexity provides a great challenge for basic and clinical research. It also raises the possibility for new targets of therapy for the metabolic syndrome. With this said, the fundamental challenge is how to intervene at the public health level to reduce the high prevalence of obesity in the general population. This approach offers the greatest possibility for reducing the cardiovascular risk that accompanies obesity.

UR - http://www.scopus.com/inward/record.url?scp=2942675088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942675088&partnerID=8YFLogxK

U2 - 10.1210/jc.2004-0372

DO - 10.1210/jc.2004-0372

M3 - Article

C2 - 15181029

AN - SCOPUS:2942675088

VL - 89

SP - 2595

EP - 2600

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -